Dementia and Alzheimer Disease

Epilepsy

Headache and Migraine

Movement Disorders

Multiple Sclerosis

Neuromuscular

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

eNewsletter

Print Subscription

Articles

Here's some of what is coming soon to NeurologyLive® this week.

This Week on NeurologyLive® — March 27, 2023

NurOwn, an autologous mesenchymal stromal cell approach for ALS, failed to meet its primary end point in a pivotal phase 3 trial, but showed promising results on less severe forms of the disease in subsequent analyses.

BrainStorm Announces FDA AdComm Meeting for NurOwn Stromal Cell Therapy

In honor of Purple Day, held on March 26, 2023, get caught up on some of the latest news in epilepsy as the NeurologyLive® team shares some of our data updates.

Neuro News Roundup: Purple Day

Videos

The child neurologist at the University of Colorado School of Medicine talked about her presentation on end of life care for patients with neuromuscular diseases at the 2023 MDA conference. [WATCH TIME: 5 minutes]  

Standardizing Clinical Practice for End of Life Care in Neuromuscular Diseases: Lauren Treat, MD

The neurologist and migraine expert from NYU Langone Health.

The neurologist and migraine expert from NYU Langone Health shared her reactions to the recently approved zavegepant nasal spray (Zavzpret; Pfizer) for the treatment of migraine. [WATCH TIME: 5 minutes]  

Newly Approved Migraine Nasal Spray Offers Alternative Treatment to Injections, Oral Medications: Shae Datta, MD

Slideshows

Here's the latest multidisciplinary MS research published online first in the International Journal of MS Care.

IJMSC Online First: March 2023

Director, Comprehensive Epilepsy Center, NYU Langone Health

The director of the Comprehensive Epilepsy Center at NYU Langone discussed the importance of healthy eating habits and whether all individuals with epilepsy should consider dieting early in their life. [WATCH TIME: 4 minutes]

Importance of Establishing Healthy Eating Habits in Epilepsy: Orrin Devinsky, MD

The vascular neurologist at Cleveland Clinic provided an overview of a study that assessed the extent HbA1c impacts the relationship between mechanical thrombectomy and poor outcomes. [WATCH TIME: 3 minutes]

Effect of HbA1c Elevation, Glycemic Control Following Mechanical Thrombectomy: David Baker, DO

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

Spotlight

MDA 2023

NMOSD

Narcolepsy

Parkinson Disease

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

1rem

View

About 30% of patients with periodic paralysis have unknown genetic mutation, making identification and treatment a challenge. Here: key points on genetics, testing, and subtypes of PPP.

Rare Diseases

Clinical

A Rare Genetic Disorder That Causes Episodes of Flaccid Paralysis

A Rare Genetic Disorder That Causes Episodes of Flaccid Paralysis

5 Pending FDA Decisions in Neurology to Look for in 2023

Phase 2 Trial for Angelman Syndrome Underway

Out-of-Pocket Costs Steadily Increasing for Neurologic Care

Curious Results in Myasthenia Gravis Study

Initial Results Prove Positive for Low-Dose AXO-AAV-GM1 in GM1 Gangliosidosis

GW Submits sNDA for CBD in Tuberous Sclerosis Complex

5 Pending FDA Decisions in Neurology to Look for in 2023

Phase 2 Trial for Angelman Syndrome Underway

Out-of-Pocket Costs Steadily Increasing for Neurologic Care

Curious Results in Myasthenia Gravis Study

Initial Results Prove Positive for Low-Dose AXO-AAV-GM1 in GM1 Gangliosidosis

GW Submits sNDA for CBD in Tuberous Sclerosis Complex

5 Pending FDA Decisions in Neurology to Look for in 2023

Phase 2 Trial for Angelman Syndrome Underway

Out-of-Pocket Costs Steadily Increasing for Neurologic Care

Curious Results in Myasthenia Gravis Study

Initial Results Prove Positive for Low-Dose AXO-AAV-GM1 in GM1 Gangliosidosis

GW Submits sNDA for CBD in Tuberous Sclerosis Complex